Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The brain microvascular endothelial paracellular tight junction barrier is a highly specialized multi-protein complex that seals the space between endothelial cells in the brain's capillaries, forming the core of the blood-brain barrier (BBB) (Abbott et al., 2010, Nature Reviews Neuroscience). It consists of transmembrane proteins, including claudin-5, occludin, and junctional adhesion molecules (JAMs), which interact with neighboring cells to restrict the paracellular diffusion of solutes and ions (Nitta et al., 2003, Journal of Cell Biology). These proteins are linked to the actin cytoskeleton via scaffolding proteins such as zonula occludens-1 (ZO-1), which are essential for maintaining the structural integrity and signaling functions of the barrier (Fanning et al., 1998, Journal of Biological Chemistry). Dysfunction of this barrier is a hallmark of various neurological disorders, including ischemic stroke, multiple sclerosis, and Alzheimer's disease, where increased permeability leads to neuroinflammation and edema (Zlokovic, 2011, Nature Reviews Neuroscience). In drug development, this barrier is both a challenge and a target; researchers utilize osmotic agents like mannitol or specific modulators like regadenoson to transiently increase permeability for the delivery of therapeutic agents (Carman et al., 2011, Journal of Neuroscience). However, therapeutic targeting must be carefully controlled to avoid the influx of neurotoxic substances or pathogens into the brain parenchyma.
Osmotic induction of endothelial cell shrinkage, competitive inhibition of extracellular junctional protein loops, and adenosine receptor-mediated signaling to transiently increase paracellular permeability.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain microvascular endothelial paracellular tight junction barrier (BBB-TJ).